preloader logo

Investor Relations

Changing the scale of what’s possible…

Nautilus Biotechnology seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. By integrating breakthrough innovations in computer science, engineering, and biochemistry we have designed a large-scale, single-molecule proteomic analysis technology capable of delivering extreme sensitivity and scale.

By enabling an expansion of both the depth and breadth of proteomic studies, Nautilus’ technology has the potential to revolutionize how biological research is conducted, drugs are identified and developed, and human disease is treated.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.